Our blog

The EUS can be used to diagnose and treat a variety of conditions, including pancreatic cancer, gall bladder cancer, oesophageal cancer, Barrett’s oesophagus, gastric cancer, diseases of the liver, spleen, kidneys, IBD and much more.

The capsule endoscopy market is not only expanding but is poised to reach a staggering global value of over $1.09 trillion by 2030. What is driving this unprecedented growth? Tanya Ridding explores the capsule endoscopy market's transformative rise.

Colorectal Cancer stands as the third leading cause of cancer-related deaths in the US. Early detection through colonoscopies is crucial for preventing the progression of CRC. However, high missed detection rates pose a challenge, putting patients at risk even with regular screenings.

With countless brain advancement studies throughout the world, some have been summarized in a recent posting from LiveScience. Hollie Bevan reflects on brain advancement studies throughout the world in 2023.

SprintRay Inc. is a 3D Printer manufacturer focused on digital dentistry. The company's products empower dentists to respond quickly to their patients and expand treatment offerings. We spoke with Senior Manager Regional DSO Mike Baker.

We spoke to Dentreads Founder Sharad Sahai and Executive Vice President Shy Kottal, finding out their thoughts on the 3D Printing industry and how technology is shaping the future of the industry.

Our 'Spotlight On' series interviews individuals across the medical, pharmaceutical and scientific industries, revealing the driving forces behind their company's success. In this interview, we spoke with Elon Bar Lev, Sales Director at CitoForma.

Our aim is to inspire the next generation of women with advice for those either considering joining the industry or hoping to progress in their careers. We spoke to Sharon Bournes, VP of Customer Marketing & Engagement, about her experience in the industry.

3D printing is rapidly gaining prominence in the dental industry, with an expected growth rate of 25% by 2030. However, its potential in clinical settings remains unclear. We spoke with James Bonham, CEO of Voxel Dental Solutions, to find out his perspective on the fast-changing industry.